not long now, page-3

Hi, ruff

I , too, think that OBJ is worth more than its current market cap indicates. But without any revenue/earning, the market cap of obj will be mostly influenced by market sentiment, imo.

I also see the risky side of OBJ business from a shareholder’s view: For example:

1 what if 2007 is sort of repeat of 2006: announcements on progress of OBJ tech, talks of discussion with pharma, no revenue, no deal and another share placement?

2. In the annual report, it mentioned Cosmetic/ Life Style Delivery Systems (OBJ wearable watch patch). My interpretation is that OBJ will want to start the production of the patches, which I perceive as a negative. Why so? Because I perceive OBJ board as mostly a science team. Do they have the capacity to actually mange a successful manufacture business? Do they have the necessary facilities? (such as marketing, sales distribution, etc) to actually sell the patches successfully? I doubt it. The team does scientific work best. So I would like to think that doing more tests / trials and licensing its technology is the way to go. Not wise to get involved in the production business.

The above is just my personal opinion.

A pharma deal to license OBJ’s technology that brings royalties will be really good to the company and its shareholders.

Please do your own research